SUNPHARMA

SUN PHARMA: GETS SOUTH AFRICA APPROVAL FOR GENERIC SEMAGLUTIDE 💉🌍 • 🇿🇦 Sun Pharma has received approval from SAHPRA to manufacture and market generic semaglutide injection in South Africa • 🩺 The drug is indicated for adults with Type 2 diabetes as an adjunct to diet and exercise • 🚀 Commercial launch is planned in the coming days • 💉 Product will be available in pre-filled, multi-dose pens with 2 mg/1.5 mL and 4 mg/3 mL strengths for once-weekly dosing • 🌍 South Africa becomes the second market after India where Sun Pharma has secured approval for generic semaglutide 🟢 Impact: Positive (Expands Sun Pharma's diabetes portfolio and strengthens its presence in international generic GLP-1 markets.)